Immune evasion in cancer: Mechanistic basis and therapeutic strategies
2015 · Seminars in Cancer Biology · 1,631 citations
https://doi.org/10.1016/j.semcancer.2015.03.004
J
John Stagg
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
269
Papers
18.9K
Citations
56
h-index
101
i10-index
John Stagg is an academic researcher from Centre Hospitalier de l’Université de Montréal. The author has contributed to research in topics: Adenosine and Purinergic Signaling & Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction. The author has an h-index of 56, co-authored 229 publications.
ORCID: 0000-0001-7833-4228Papers by this author
worksThe ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets
2017 · Immunological Reviews · 849 citations
https://doi.org/10.1111/imr.12528
Anti–ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti–PD-1 or anti-CD137 mAb therapy
2011 · Proceedings of the National Academy of Sciences · 481 citations
https://doi.org/10.1073/pnas.1016569108
Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers
2019 · Journal of Clinical Investigation · 406 citations
https://doi.org/10.1172/jci96313
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
2017 · Journal of Clinical Investigation · 310 citations
https://doi.org/10.1172/jci89455
Designing a broad-spectrum integrative approach for cancer prevention and treatment
2015 · Seminars in Cancer Biology · 294 citations
https://doi.org/10.1016/j.semcancer.2015.09.007
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat